【摘 要】
:
Pulmonary artery hypertension(PAH)is a chronic progressive disease characterized by persistent elevation of pulmonary arterial vascular pressure.The disease severely limits the function of the right v
【机 构】
:
Department of Pharmacy,Zhu Jiang Hospital,Southern Medical University,Guangzhou 510282,China
论文部分内容阅读
Pulmonary artery hypertension(PAH)is a chronic progressive disease characterized by persistent elevation of pulmonary arterial vascular pressure.The disease severely limits the function of the right ventricular,causing organ failure and finally leading to death.Despite significant advances in pharmacological treatments,PAH remains an incurable disease with high morbidity and mortality.The histopathological change of PAH is featured by remodeling of the pulmonary vascular.Abnormal proliferation of pulmonary artery smooth muscle cells(PASMCs)in peripheral vascular is one major pathological finding of pulmonary vascular remodeling.Current therapeutics available for PAH primarily aim at inhibiting the pulmonary vasoconstriction and resisting pulmonary vascular remodeling.To date,only some inhibitors targeting proliferative signaling pathways have been used to suppress the proliferation of PASMCs and reverse pulmonary vascular remodeling.However,due to serious side effects their clinical use is limited and more validation is needed before the inhibitors can be transferred into clinical use.This review will focus on signal mechanisms involved in the development of PAH from a view of cell proliferation,and give an overview of recent advances in research on inhibitors targeting proliferative pathways.
其他文献
心衰恶化和住院的主要原因。Chaudhry等人研究:因心衰而住院的患者在住院前30田体重就开始增加。而未住院的患者体重没有明显变化(P<0.001)人类去除体液潴留的探索西方油画中关于放血的描绘2014年中国心衰指南-推荐的利尿剂利尿药作用位点和分类.
The combination of a chemotherapeutic drug with a chemosensitizer has emerged as a promising strategy for cancers showing multidrug resistance(MDR).Herein we describe the simultaneous targeted deliver
Development of multidrug resistance against chemotherapeutic drugs is one of the major obstacles to successful cancer therapy in the clinic.Thus far,amphiphilic polymeric micelles and chemosensitizers
目的:观察四磨汤口服液联合杜秘克(乳果糖)治疗老年功能性便秘的临床疗效.方法:将90例老年功能性便秘患者随机分为治疗组、对照A组、对照B组,每组30例.治疗组患者口服四磨汤口服液每次20ml,每天3次+乳果糖每次30ml,每天早餐时服用,2d后无明显效果者酌情加量至60ml;对照A组患者口服四磨汤口服液每次20ml,每天3次;对照B组患者口服乳果糖每次15ml,每天早餐时服用,2d后无明显效果者酌
目的:运用我院制定的《分病种(手术)合理用药指标体系和评价细则》评价我院主动脉瓣机械(生物)瓣置换术、二尖瓣生物(机械)瓣置换术预防用抗菌药物的合理性.方法:研究2013年~2014年我院四种心脏瓣膜手术出院病历368例围手术期抗菌药物的合理情况,按照我院制定的《细则》从用药指征、用药选择、用药过程、用药结果四大方面综合分析评分.结果:本调查的368病例围手术期均使用抗菌药物,评价得分结果介于之间
目的:探讨治疗伴有精神症状的青少年抑郁症患者的最佳药物治疗方案.方法:从某三甲医院精神及心理病区的治疗病例中,筛选出4组不同的用于治疗青少年抑郁症的药物治疗方案,分别是喹硫平+度洛西汀组、文拉法辛+利培酮组、奥氮平+度洛西汀组、喹硫平+舍曲林组进行成本-效果分析、ADR比较、敏感度分析;数据用SPSS统计软件处理,经卡方检验、方差分析求得P值.结果:喹硫平+度洛西汀组、文拉法辛+利培酮组、奥氮平+
临床药师参与难治性肺部感染的治疗,首先要明确感染性疾病的诊断,排除肺感染性的发病因素,关注药物热,防止药品不良反应;第二看是否有耐药菌的感染;第三看是否有特殊病原菌的感染;第四考虑患者自身身体因素。目前很多医院临床用药中存在多种不合理现象,特别是抗感染治疗,临床药师应该做出自己的努力。
目的:了解我院门诊口服治疗肺动脉高压药物的应用情况,为临床合理用药提供参考.方法:抽取我院2013-2015年14-60岁肺动脉高压门诊患者处方数据,采用世界卫生组织(WHO)推荐的限定日剂量(DDD)方法,对我院口服治疗肺动脉高压药物的用药频度(DDDs)、日用药金额(DDC)、药物利用指数(DUI)进行统计分析.结果:DDDs三年都排序前三的药物依次为他达拉非片、螺内酯片、呋塞米片;DDC三年
To evaluate the independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and atorvastatin metabolism,the relationships among three levels of factors,namely(1)clinical c
目的:建立胰岛素自微乳剂油相中胰岛素含量的测定方法.方法:采用反向HPLC法,分别测定:1.自微乳剂中总胰岛素的含量C总;2.自微乳剂水相中胰岛素的含量C水.自微乳剂油相中胰岛素的含量C油=C总-C水.色谱条件:色谱柱SinoChrom ODS-AP(4.6nm×250mm;5um),0.1mol/L磷酸二氢钠水溶液-乙腈(73:27,ph=2.3)为流动相,流速为1mL/min,柱温40℃,检测